Oncotarget
Academic journal
From Wikipedia, the free encyclopedia
Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. The journal was established in 2010 and is published by Impact Journals. The editors-in-chief are Mikhail Blagosklonny and Andrei V. Gudkov.
| Discipline | Oncology |
|---|---|
| Language | English |
| Edited by | Mikhail Blagosklonny, Andrei V. Gudkov |
| Publication details | |
| History | 2010–present |
| Publisher | Impact Journals |
| Frequency | Continuous Publication |
| Yes | |
| License | Creative Commons Attribution 3.0 License |
| Standard abbreviations | |
| ISO 4 | Oncotarget |
| Indexing | |
| ISSN | 1949-2553 |
| OCLC no. | 408119940 |
| Links | |
Abstracting and indexing
The journal is abstracted and indexed in Index Medicus/MEDLINE/PubMed[1] and Scopus.[2] In 2022, it was re-indexed by Index Medicus/MEDLINE[3] after being dropped in 2017.[4][5][1] In 2018 Clarivate delisted the journal from the Journal Citation Reports and all of its other products because "the journal no longer meets the standards necessary for continued coverage", despite having listed the journal as a "Rising Star from Essential Science Indicators"[6] only a few months prior.[7]
Reception
The peer review process employed by the journal has been criticized by Jeffrey Beall,[8] a university librarian and expert on predatory open access publishing, who also included the journal on his list of "potential, possible, or probable predatory scholarly open-access journals" in July 2015.[8][9] Allegedly, journal editor Mikhail Blagosklonny responded by threatening to retract the papers of Beall's colleagues at the University of Colorado.[4][5]
